Tue, Jun 18, 2013, 8:02 PM EDT - U.S. Markets closed
This will prolong the ultimate death of Vivus. Doesn't change the fact that Drs. will not prescribe this generic coctail.
Your probably right about cheap far out options being bought. I think a push to get CEO out a brilliant scientist but lacking as a CEO. Kirk will bring in someone more intuned to his synthetic program.